MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).

Autor: Pavic, M.1 (AUTHOR) m.pavic@gmx.net, Niyazi, M.2 (AUTHOR), Wilke, L.1 (AUTHOR), Corradini, S.2 (AUTHOR), Vornhülz, M.3,4 (AUTHOR), Mansmann, U.5 (AUTHOR), Al Tawil, A.5 (AUTHOR), Fritsch, R.6 (AUTHOR), Hörner-Rieber, J.7,8 (AUTHOR), Debus, J.7,8 (AUTHOR), Guckenberger, M.1 (AUTHOR), Belka, C.2,4 (AUTHOR), Mayerle, J.3,4 (AUTHOR), Beyer, G.3,4 (AUTHOR)
Zdroj: Radiation Oncology. 1/25/2022, Vol. 17 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje